Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Molecular mechanisms of lipid disorders in nephrotic syndrome.

Literature DB >> 12675893

Molecular mechanisms of lipid disorders in nephrotic syndrome.

Nosratola D Vaziri.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2003 PMID： 12675893 DOI： 10.1046/j.1523-1755.2003.00941.x

Source DB: PubMed Journal: Kidney Int ISSN： 0085-2538 Impact factor: 10.612

Keyword Cloud
Cited

× No keyword cloud information.

36 in total

1. Factors associated with renal dysfunction within an urban HIV-infected cohort in the era of highly active antiretroviral therapy.

Authors: E T Overton; D Nurutdinova; J Freeman; W Seyfried; K E Mondy
Journal: HIV Med Date: 2009-03-11 Impact factor: 3.180

Review 2. Nephrotic syndrome: components, connections, and angiopoietin-like 4-related therapeutics.

Authors: Camille Macé; Sumant S Chugh
Journal: J Am Soc Nephrol Date: 2014-05-22 Impact factor: 10.121

3. Apolipoprotein B attenuates albuminuria-associated cardiovascular disease in prevention of renal and vascular endstage disease (PREVEND) participants.

Authors: James P Corsetti; Ron T Gansevoort; Stephan J L Bakker; Charles E Sparks; Priya Vart; Robin P F Dullaart
Journal: J Am Soc Nephrol Date: 2014-05-22 Impact factor: 10.121

Review 4. Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences.

Authors: Nosratola D Vaziri
Journal: Kidney Int Date: 2016-04-26 Impact factor: 10.612

5. DESI-MSI and METASPACE indicates lipid abnormalities and altered mitochondrial membrane components in diabetic renal proximal tubules.

Authors: Guanshi Zhang; Jialing Zhang; Rachel J DeHoog; Subramaniam Pennathur; Christopher R Anderton; Manjeri A Venkatachalam; Theodore Alexandrov; Livia S Eberlin; Kumar Sharma
Journal: Metabolomics Date: 2020-01-10 Impact factor: 4.290

Review 10. Reasons for the lack of salutary effects of cholesterol-lowering interventions in end-stage renal disease populations.

Authors: Nosratola D Vaziri; Keith C Norris
Journal: Blood Purif Date: 2013-01-22 Impact factor: 2.614

Molecular mechanisms of lipid disorders in nephrotic syndrome.

1. Factors associated with renal dysfunction within an urban HIV-infected cohort in the era of highly active antiretroviral therapy.

Review 2. Nephrotic syndrome: components, connections, and angiopoietin-like 4-related therapeutics.

3. Apolipoprotein B attenuates albuminuria-associated cardiovascular disease in prevention of renal and vascular endstage disease (PREVEND) participants.

Review 4. Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences.

5. DESI-MSI and METASPACE indicates lipid abnormalities and altered mitochondrial membrane components in diabetic renal proximal tubules.

Review 6. Biology of proprotein convertase subtilisin kexin 9: beyond low-density lipoprotein cholesterol lowering.

7. Diminished macrophage cholesterol removal rate by the altered HDL metabolism in the Nagase analbuminemic rat.

Review 8. Causes of dysregulation of lipid metabolism in chronic renal failure.

Review 9. High-density lipoprotein in uremic patients: metabolism, impairment, and therapy.

Review 10. Reasons for the lack of salutary effects of cholesterol-lowering interventions in end-stage renal disease populations.